Background Anticardiolipin antibodies of the immunoglobulin G isotype (IgG aCL) have
been suggested as risk factor for arterial and venous thrombosis. No conclusive data in …

Background—The association of anticardiolipin (aCL) antibodies with coronary artery
disease has been shown in several studies but remains controversial. We evaluated the …

PURPOSE: Anticardiolipin antibodies may be associated with recurrent thromboembolic
events in patients with myocardial infarction or stroke. We sought to determine the …

Background and Purpose—Anticardiolipin antibodies (aCL) have been proposed to be an
independent risk factor for stroke. To test this hypothesis, a nested case-control study was …

Objective: To investigate associations between cerebrovascular risk factors and
anticardiolipin (aCL) immunoreactivity. Background: High titers of aCL immunoreactivity …

Objective. We studied antiphospholipid antibodies (aPL) in blood samples from a cohort of
individuals followed for thrombosis to determine whether the persistent presence of …

Our objective was to identify the role of various disease states and additional risk factors in
the development of thrombosis in patients with anticardiolipin antibodies (aCL). We …

Background Anticardiolipin antibodies (aCL) have been associated with an increased risk of
stroke and thrombo-occlusive events. Little is known about the influence of aCL on recurrent …

Background—It has been hypothesized that immunoreactivity to β2-glycoprotein 1 (β2GP1)-
dependent anticardiolipin antibody (aCL), but not β2GP1-independent aCL, is associated …

Background Data concerning the relation between anti-phospholipid (aPL) antibodies and
myocardial infarction in subjects without evidence of overt autoimmune disease are …